Article
Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients.
Journal of cellular and molecular medicine - 1 Apr 2018
Pan Chang, Zhao Yu, Bian Yuan, Shang Rui, Wang Jia-Li, Xue Li, Wei Shu-Jian, Zhang He, Chen Yu-Guo, Xu Feng
Abstract excerpt
Aldehyde dehydrogenase 2 (ALDH2) Glu504Lys variant was an independent risk factor for acute coronary syndrome (ACS). However, there are lacking researches about the relationship between the variant and prognosis of ACS. In the prospective study, 377 ACS patients were grouped into the wild-type (*1/*1) and the mutation (*2/*2 + *1/*2) groups according to genotype detection. Compared with the wild-type group,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
